Key Events This Week
15 Jun: New 52-week and all-time high at Rs.1,306.20; upgraded to Buy rating
16 Jun: Stock declined 2.01% amid broader market gains
17 Jun: Price recovery with 1.13% gain supported by steady volumes
18 Jun: New 52-week and all-time high at Rs.1,318.25; outperformed Sensex
19 Jun: Marginal gain of 0.09% closing at Rs.1,315.15; slight Sensex dip

Broad-Based Technical Strength Lifts Senores Pharmaceuticals Ltd to 52-Week High of Rs 1318.25
2026-06-18 10:41:10With a remarkable surge to Rs 1318.25 on 18 Jun 2026, Senores Pharmaceuticals Ltd has reached a new 52-week and all-time high, propelled by a confluence of strong technical signals and sustained price momentum.
Read full news article
Senores Pharmaceuticals Ltd Hits All-Time High of Rs 1,312 as Momentum Builds Across Timeframes
2026-06-18 10:03:57Extending its recent rally, Senores Pharmaceuticals Ltd touched a fresh all-time high of Rs 1,312 on 18 Jun 2026, outperforming its sector and the broader market with a notable 3.07% gain on the day.
Read full news article
Broad-Based Technical Strength Lifts Senores Pharmaceuticals Ltd to 52-Week High of Rs 1306.2
2026-06-15 10:01:35With a remarkable ascent from Rs 507 to Rs 1306.2 over the past year, Senores Pharmaceuticals Ltd has more than doubled its share price, reaching a fresh 52-week high on 15 Jun 2026. This milestone underscores a sustained momentum driven by a confluence of robust technical indicators and steady fundamental growth.
Read full news article
Senores Pharmaceuticals Upgraded to Buy on Strong Technicals and Financial Momentum
2026-06-15 08:15:58Senores Pharmaceuticals Ltd has been upgraded from a Hold to a Buy rating, reflecting significant improvements across technical indicators, valuation metrics, financial trends, and overall quality. This upgrade comes amid robust stock price appreciation, strong quarterly results, and positive institutional interest, positioning the company favourably within the Pharmaceuticals & Biotechnology sector.
Read full news article
Senores Pharmaceuticals Ltd Sees Strong Technical Momentum Shift Amid Robust Price Gains
2026-06-15 08:05:56Senores Pharmaceuticals Ltd has witnessed a significant price momentum shift, marked by a strong technical uptrend and an upgrade in its MarketsMOJO Mojo Grade from Hold to Buy. The stock’s recent surge of 11.35% in a single day, coupled with robust weekly and monthly technical indicators, signals renewed investor confidence in this small-cap pharmaceutical player.
Read full news article
Senores Pharmaceuticals Ltd is Rated Buy
2026-06-14 10:10:29Senores Pharmaceuticals Ltd is rated Buy by MarketsMOJO, with this rating last updated on 12 June 2026. While the rating change occurred on that date, the analysis and financial metrics presented here reflect the stock’s current position as of 14 June 2026, providing investors with the most up-to-date view of the company’s fundamentals and market performance.
Read full news articleSenores Pharmaceuticals Drops 7.44%: Volatility and Technical Shifts Define Week
2026-06-13 15:05:32
Key Events This Week
1 June: Stock opens with a significant gap down, closing at Rs.1,067.75 (-4.49%)
2 June: Technical momentum shifts amid mixed indicator signals, stock closes at Rs.1,036.55 (-2.92%)
3 June: Minor recovery with a 1.18% gain, closing at Rs.1,048.80
4 June: Slight decline of 0.56%, closing at Rs.1,042.95
5 June: Week ends with a 0.78% drop, closing at Rs.1,034.80
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available







